Compare BAOS & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAOS | PPCB |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.2M |
| IPO Year | 2021 | N/A |
| Metric | BAOS | PPCB |
|---|---|---|
| Price | $2.70 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.8K | ★ 3.2M |
| Earning Date | 05-08-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $860,951.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.20 | N/A |
| 52 Week Low | $1.52 | $0.16 |
| 52 Week High | $8.30 | $11.00 |
| Indicator | BAOS | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 33.11 |
| Support Level | $2.60 | $0.16 |
| Resistance Level | $2.86 | $0.24 |
| Average True Range (ATR) | 0.23 | 0.05 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 14.29 | 23.07 |
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.